Pyxis Oncology, Inc.PYXSNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | -100.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | -100.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +46.90% | +35.66% | +19.03% | +2.35% | +3.03% |
| Weighted Average Shares Diluted Growth | +46.90% | +35.66% | +19.03% | +2.35% | +3.03% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -100.00% | -100.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +4.62% | -9.52% | -38.30% | -40.87% | -45.93% |
| Book Value per Share Growth | -24.16% | -29.19% | -52.96% | -49.57% | -56.56% |
| Debt Growth | -4.99% | -5.30% | -4.51% | -6.76% | -7.14% |
| R&D Expense Growth | +20.79% | +20.82% | +30.82% | +22.79% | +0.38% |
| SG&A Expenses Growth | -43.63% | -17.52% | -28.82% | -10.56% | -17.36% |